Publications by authors named "Eugene B McLaurin"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

1,473

Total Likes

39

Extended Reach

1,484

Social Features

102
P
Pilocarpine HCl 1.25% for treatment of presbyopia after laser vision correction: pooled analysis of two phase 3 randomized trials (GEMINI 1 and 2).
Chris W Lievens, Milton M Hom, Eugene B McLaurin, Jiang Yuan, Eleonora Safyan, Haixia Liu

J Cataract Refract Surg· January 2024

Videos about Article: user user

2 100

View All Article and Social Media Activity
A
Acoltremon Ophthalmic Solution 0.003% for Signs and Symptoms of Dry Eye Disease: Results of Phase 3 Pivotal COMET-2 and COMET-3 Studies.
Guruprasad R Pattar, David Wirta, Gary Jerkins, James Paauw, Eugene B McLaurin

Ophthalmology· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study.
Jason Bacharach, Eugene B McLaurin, Steven Silverstein, Mourad Amrane, Jean-Sebastien Garrigue

J Ocul Pharmacol Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Multicenter Phase 3 Clinical Trial Evaluating Intracanalicular Dexamethasone Insert for the Treatment of Allergic Conjunctivitis.
Kenneth Kenyon, Eugene B McLaurin, Steven M Silverstein, John C Meyer, Erik Anderson

Clin Ophthalmol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omidenepag Isopropyl in Latanoprost Low/Nonresponders With Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 3, Nonrandomized, Two-Phase, Open-Label Study.
Joseph F Panarelli, Eileen C Bowden, Michael E Tepedino, Noriko Odani-Kawabata, Zifan Pei, Eugene B McLaurin

J Glaucoma· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of the Melanocortin Pan-Agonist PL9643 in a Phase 2 Study of Patients with Dry Eye Disease.
David Evans, Kenneth Kenyon, George Ousler, Michael Watson, Patrick Vollmer, Eugene B McLaurin

J Ocul Pharmacol Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, vehicle-controlled, Phase 2b study of two concentrations of the TRPM8 receptor agonist AR-15512 in the treatment of dry eye disease (COMET-1).
David L Wirta, Michelle Senchyna, Amber E Lewis, David G Evans, Eugene B McLaurin

Ocul Surf· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 Randomized Study of Efficacy and Safety of a Dexamethasone Intracanalicular Insert in Patients With Allergic Conjunctivitis.
Eugene B McLaurin, David Evans, Carolyn S Repke, Michelle A Sato, Paul J Gomes

Am J Ophthalmol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Pharmacokinetic Parameters of Dexamethasone Following Administration of a Dexamethasone Intracanalicular Insert in Healthy Adults.
Charles Blizzard, Eugene B McLaurin, Arthur Driscoll, Fabiana Q Silva, Srilatha Vantipalli

Clin Ophthalmol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials.
Joseph B Ciolino, Eugene B McLaurin, Nicholas P Marsico, Stacey L Ackerman, Julia M Williams

Clin Ophthalmol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular itch relief with alcaftadine 0.25% versus olopatadine 0.2% in allergic conjunctivitis: pooled analysis of two multicenter randomized clinical trials.
Eugene B McLaurin, Nicholas P Marsico, Stacey L Ackerman, Joseph B Ciolino, Julia M Williams

Adv Ther· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.
John D Sheppard, Gail L Torkildsen, John D Lonsdale, Francis A D'Ambrosio, Eugene B McLaurin

Ophthalmology· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 randomized, double-masked, placebo-controlled study of a novel integrin antagonist (SAR 1118) for the treatment of dry eye.
Charles P Semba, Gail L Torkildsen, John D Lonsdale, Eugene B McLaurin, Joel A Geffin

Am J Ophthalmol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis